• Immupharma held its annual general meeting earlier today, with all six shareholder resolutions carried.
• Shareholders accepted the annual accounts for the year ended Dec. 31, 2025.
• Crowe UK was reappointed as auditor.
• Shareholders granted the board authority to allot shares, including under a special resolution.
• A special resolution adopted new articles of association, replacing the existing articles, effective from the meeting’s conclusion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immupharma plc published the original content used to generate this news brief on July 22, 2026, and is solely responsible for the information contained therein.